OR2T29
gene geneOn this page
Summary
OR2T29 (olfactory receptor family 2 subfamily T member 29, HGNC:31253) is a protein-coding gene on chromosome 1q44, encoding Olfactory receptor 2T29 (Q8NH02). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 343563 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 10 total
- MANE Select transcript:
NM_001004694
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31253 |
| Approved symbol | OR2T29 |
| Name | olfactory receptor family 2 subfamily T member 29 |
| Location | 1q44 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000182783 |
| Ensembl biotype | protein_coding |
| Entrez | 343563 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000328570, ENST00000641069
RefSeq mRNA: 1 — MANE Select: NM_001004694
NM_001004694
CCDS: CCDS55695
Canonical transcript exons
ENST00000641069 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003812881 | 248562726 | 248562772 |
| ENSE00003813973 | 248556912 | 248559501 |
Expression profiles
Bgee: expression breadth broad, 16 present calls, max score 81.53.
Top tissues by expression
119 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.53 | gold quality |
| granulocyte | CL:0000094 | 39.02 | gold quality |
| sural nerve | UBERON:0015488 | 38.47 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| vermiform appendix | UBERON:0001154 | 36.90 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 36.45 | gold quality |
| lymph node | UBERON:0000029 | 36.36 | silver quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| tonsil | UBERON:0002372 | 36.04 | silver quality |
| kidney | UBERON:0002113 | 35.58 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| primary visual cortex | UBERON:0002436 | 33.70 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| cortex of kidney | UBERON:0001225 | 31.01 | gold quality |
| right uterine tube | UBERON:0001302 | 30.59 | gold quality |
| metanephros cortex | UBERON:0010533 | 30.56 | gold quality |
| prefrontal cortex | UBERON:0000451 | 30.55 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 30.47 | gold quality |
| leukocyte | CL:0000738 | 30.00 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| monocyte | CL:0000576 | 29.53 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 29.04 | gold quality |
| minor salivary gland | UBERON:0001830 | 29.03 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| placenta | UBERON:0001987 | 27.74 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.81 |
Regulation
Is transcription factor: no
Cross-species orthologs
14 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or2t48 | ENSMUSG00000050818 |
| mus_musculus | Or2t47 | ENSMUSG00000057654 |
| mus_musculus | Or2t49 | ENSMUSG00000058807 |
| mus_musculus | Or2t43 | ENSMUSG00000059279 |
| mus_musculus | Or2t46 | ENSMUSG00000060765 |
| mus_musculus | Or2t29 | ENSMUSG00000064252 |
| rattus_norvegicus | Or2t48 | ENSRNOG00000068864 |
| rattus_norvegicus | Or2t47 | ENSRNOG00000072569 |
| rattus_norvegicus | ENSRNOG00000074273 | |
| rattus_norvegicus | Or2t47e | ENSRNOG00000076869 |
| rattus_norvegicus | Or2t48d | ENSRNOG00000079170 |
| rattus_norvegicus | Or2t47d | ENSRNOG00000079612 |
| rattus_norvegicus | ENSRNOG00000081472 | |
| rattus_norvegicus | Olr1428 | ENSRNOG00000083977 |
Paralogs (92): OR2B6 (ENSG00000124657), OR13C9 (ENSG00000136839), OR13C4 (ENSG00000148136), OR2M5 (ENSG00000162727), OR10A5 (ENSG00000166363), OR2D2 (ENSG00000166368), OR2B2 (ENSG00000168131), OR2C1 (ENSG00000168158), OR13J1 (ENSG00000168828), OR10G3 (ENSG00000169208), OR10A3 (ENSG00000170683), OR10A4 (ENSG00000170782), OR10A2 (ENSG00000170790), OR13H1 (ENSG00000171054), OR2K2 (ENSG00000171133), OR2M4 (ENSG00000171180), OR10H2 (ENSG00000171942), OR10H5 (ENSG00000172519), OR10AD1 (ENSG00000172640), OR2Y1 (ENSG00000174339), OR10AG1 (ENSG00000174970), OR2T1 (ENSG00000175143), OR10P1 (ENSG00000175398), OR2T35 (ENSG00000177151), OR2M7 (ENSG00000177186), OR2T12 (ENSG00000177201), OR2T33 (ENSG00000177212), OR2AJ1 (ENSG00000177275), OR2T8 (ENSG00000177462), OR2G3 (ENSG00000177476), OR2G2 (ENSG00000177489), OR2B11 (ENSG00000177535), OR2D3 (ENSG00000178358), OR13D1 (ENSG00000179055), OR10A7 (ENSG00000179919), OR2Z1 (ENSG00000181733), OR2V2 (ENSG00000182613), OR10G7 (ENSG00000182634), OR2T34 (ENSG00000183310), OR2T10 (ENSG00000184022)
Protein
Protein identifiers
Olfactory receptor 2T29 — Q8NH02 (reviewed: Q8NH02)
All UniProt accessions (1): Q8NH02
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004694* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (19 total): topological domain 8, transmembrane region 7, glycosylation site 2, chain 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NH02-F1 | 89.66 | 0.72 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 101–193
Glycosylation sites (2): 3, 9
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 18 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr1q44, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, ZHANG_FH_DEFICIENT_RCC_C2_VS_OTHERS_UP, PULVER_FOREY_PERTURB_ATTRITION_G1_S
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of smell (GO:0050911), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
176 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR2T29 | A0A087WY73 | A0A087WY73 | 601 |
| OR2T29 | CCER1 | Q8TC90 | 505 |
| OR2T29 | TBC1D26 | Q86UD7 | 480 |
| OR2T29 | F2Z2I4 | F2Z2I4 | 474 |
| OR2T29 | DEFB130A | P0DP74 | 472 |
| OR2T29 | GFY | I3L273 | 399 |
| OR2T29 | DEFB118 | Q96PH6 | 397 |
| OR2T29 | SMR3B | P02814 | 393 |
| OR2T29 | ANKRD36C | Q5JPF3 | 377 |
| OR2T29 | FRMD1 | Q8N878 | 371 |
| OR2T29 | CCDC181 | Q5TID7 | 370 |
| OR2T29 | MRPS26 | Q9BYN8 | 366 |
| OR2T29 | TAS2R43 | P59537 | 357 |
| OR2T29 | A0A140T9Z0 | A0A140T9Z0 | 354 |
| OR2T29 | GPR146 | Q96CH1 | 348 |
IntAct
0 interactions, top by confidence:
BioGRID (1): OR2T29 (Affinity Capture-MS)
ESM2 similar proteins: A6NH00, O60403, O95371, O95918, P23266, P23267, P23275, P34984, P47881, P47888, P47893, Q15619, Q5JQS5, Q5TZ20, Q60885, Q60891, Q60894, Q6IEZ7, Q7Z3T1, Q8N628, Q8NG76, Q8NG77, Q8NG97, Q8NGA6, Q8NGC4, Q8NGE3, Q8NGE9, Q8NGQ2, Q8NGQ4, Q8NGR4, Q8NGS0, Q8NGT9, Q8NGX9, Q8NGY1, Q8NGZ6, Q8NH02, Q8NH03, Q8NH04, Q8NHB1, Q8VGD6
Diamond homologs: A3KFT3, A4D2G3, A6NH00, A6NL26, A6NM03, O43869, O76000, O76001, O76002, O95006, O95221, O95371, O95918, P0C7N1, P0C7T2, P23274, P23275, P34984, P59922, Q13606, Q13607, Q5TZ20, Q60880, Q60890, Q6IEZ7, Q6IF00, Q8N127, Q8N349, Q8N628, Q8NG75, Q8NG76, Q8NG77, Q8NG80, Q8NG81, Q8NG83, Q8NG84, Q8NG85, Q8NG97, Q8NGC0, Q8NGE5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
10 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 8 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
202 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:248559220:A:AC | donor_gain | 0.8600 |
| 1:248559219:CATG:C | donor_gain | 0.8200 |
| 1:248559217:CCCA:C | donor_gain | 0.7900 |
| 1:248559222:G:T | donor_gain | 0.7800 |
| 1:248559221:TG:T | donor_gain | 0.7700 |
| 1:248558941:T:TA | donor_gain | 0.7600 |
| 1:248559304:A:C | donor_gain | 0.7600 |
| 1:248558884:A:C | donor_gain | 0.7200 |
| 1:248558879:G:C | donor_gain | 0.6900 |
| 1:248558963:C:CA | donor_gain | 0.6600 |
| 1:248559299:A:AC | donor_gain | 0.6400 |
| 1:248559204:G:GT | donor_gain | 0.6200 |
| 1:248559060:G:T | donor_gain | 0.6100 |
| 1:248558896:T:C | donor_gain | 0.6000 |
| 1:248558882:A:AC | donor_gain | 0.5700 |
| 1:248558883:C:CC | donor_gain | 0.5700 |
| 1:248559114:G:C | donor_gain | 0.5400 |
| 1:248559218:CCAT:C | donor_gain | 0.5300 |
| 1:248559392:C:CT | donor_gain | 0.5300 |
| 1:248558722:CCA:C | acceptor_gain | 0.5200 |
| 1:248559448:T:TA | donor_gain | 0.5200 |
| 1:248559451:A:AT | donor_gain | 0.5200 |
| 1:248558800:C:CC | acceptor_gain | 0.5100 |
| 1:248558807:CGG:C | acceptor_gain | 0.5100 |
| 1:248558895:A:AC | donor_gain | 0.5100 |
| 1:248559063:CCTA:C | donor_gain | 0.5000 |
| 1:248558723:CA:C | acceptor_gain | 0.4900 |
| 1:248558930:CAG:C | donor_gain | 0.4900 |
| 1:248559456:T:TA | donor_gain | 0.4800 |
| 1:248558808:G:T | acceptor_gain | 0.4700 |
AlphaMissense
2080 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:248558727:G:C | F255L | 0.914 |
| 1:248558727:G:T | F255L | 0.914 |
| 1:248558729:A:G | F255L | 0.914 |
| 1:248558949:G:C | F181L | 0.870 |
| 1:248558949:G:T | F181L | 0.870 |
| 1:248558951:A:G | F181L | 0.870 |
| 1:248559444:G:C | F16L | 0.855 |
| 1:248559444:G:T | F16L | 0.855 |
| 1:248559446:A:G | F16L | 0.855 |
| 1:248558946:G:C | F182L | 0.847 |
| 1:248558946:G:T | F182L | 0.847 |
| 1:248558948:A:G | F182L | 0.847 |
| 1:248559126:C:A | M122I | 0.823 |
| 1:248559126:C:G | M122I | 0.823 |
| 1:248559126:C:T | M122I | 0.823 |
| 1:248558607:A:C | S295R | 0.820 |
| 1:248558607:A:T | S295R | 0.820 |
| 1:248558609:T:G | S295R | 0.820 |
| 1:248558976:G:C | F172L | 0.819 |
| 1:248558976:G:T | F172L | 0.819 |
| 1:248558978:A:G | F172L | 0.819 |
| 1:248559375:G:C | F39L | 0.810 |
| 1:248559375:G:T | F39L | 0.810 |
| 1:248559377:A:G | F39L | 0.810 |
| 1:248559174:G:C | F106L | 0.801 |
| 1:248559174:G:T | F106L | 0.801 |
| 1:248559176:A:G | F106L | 0.801 |
| 1:248558622:G:C | N290K | 0.789 |
| 1:248558622:G:T | N290K | 0.789 |
| 1:248559144:A:C | F116L | 0.768 |
dbSNP variants (sampled 300 via entrez): RS1000077732 (1:248564654 C>A), RS1000186768 (1:248564236 T>A), RS1000525863 (1:248557705 C>T), RS1001837388 (1:248562972 C>T), RS1001868488 (1:248562523 C>A,T), RS1003286115 (1:248483329 G>C), RS1007729904 (1:248560086 G>A,C), RS1007744582 (1:248557530 C>G), RS1008732094 (1:248564638 G>A), RS1008766488 (1:248563802 T>C), RS1008796258 (1:248563179 C>T), RS1010268065 (1:248564674 T>A,C), RS1010510076 (1:248483311 G>A), RS1013700773 (1:248560616 T>C), RS1015953544 (1:248563019 C>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| hydroxyhydroquinone | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.